Christina Curtis, PHD

Advisor

Dr. Curtis is a world-renowned evolutionary cancer geneticist who leads a laboratory at Stanford University which leverages multi-omic data coupled with computational modeling and iterative experimentation in order to define the molecular determinants and dynamics of tumor progression and to identify robust biomarkers. Dr. Curtis’s research has helped to redefine the molecular map of breast cancer and led to new paradigms in understanding how human tumors progress. Dr. Curtis brings resistanceBio deep expertise in animal models, clinical trial design, and the science of treatment resistance

• LinkedIn
• Twitter